MedTrace Logo

Pulse Rate and Breathing Rate Accuracy

NCT06298981 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2024-03-22

No results posted yet for this study

Summary

The purpose of this study is to conduct a Breathing Rate and Pulse Rate accuracy validation comparing the NuraLogix AMC-SDK to the Reference devices, an FDA cleared End Tidal Carbon Dioxide monitor (GE Datex-Ohmeda) and a standard ECG (GE Datex-Ohmeda) derived heart rate reference. This will be done by manually scoring the collected waveform for data analysis.

Conditions

  • Pulse Rate and Breathing Rate

Interventions

DEVICE

noninvasive and investigational NuraLogix AMC-SDK

The NuraLogix AMC-SDK is a noninvasive device that allows for real-time, remote measuring using facial recordings.

Sponsors & Collaborators

  • Nuralogix Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06298981 on ClinicalTrials.gov